<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01339234</url>
  </required_header>
  <id_info>
    <org_study_id>Hicks -MS treadmill</org_study_id>
    <nct_id>NCT01339234</nct_id>
  </id_info>
  <brief_title>Supported Treadmill Training for Progressive Multiple Sclerosis</brief_title>
  <official_title>Body-weight Supported Treadmill Training in Primary Progressive Multiple Sclerosis: A Pilot Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hicks, Audrey, Ph.D.</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Multiple Sclerosis Society of Canada</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Hicks, Audrey, Ph.D.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is a pilot trial to evaluate the effects of supported treadmill walking in
      patients with primary progressive multiple sclerosis (MS) on functional and psychosocial
      outcomes. Patients will exercise three times per week over the course of 6 months and will be
      evaluated at baseline, 12 weeks and 24 weeks into the program. Follow-up testing will also be
      conducted 12 weeks after participants have stopped exercising to determined the lasting
      effects of the intervention.

      The investigators hypothesize that supported treadmill walking will be effective at improving
      physical physical function and psychosocial outcomes in patients with primary progressive MS.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The use of exercise as an adjunct to other disease modifying treatments in MS has found
      increasing support over the past decade. There is ample evidence that exercise therapy can
      improve physical measures of disability in MS, in addition to being safe and well-tolerated.
      However, there is a paucity of data on whether exercise is equally effective for those with
      primary progressive MS as it is in relapsing remitting MS. In addition, studies of exercise
      therapy have traditionally excluded MS patients with severe disability. There are also
      currently no treatments for primary progressive MS, so finding a safe disease-modifying
      therapy is of the utmost importance. The investigators are therefore conducting a pilot trial
      to evaluate the effects of exercise in the form of supported treadmill walking for patients
      with primary progressive MS with severe functional impairments.

      Six patients with primary progressive MS with high disability level will be recruited to
      participate in this study. Participants will exercise using body-weight supported treadmill
      training (BWSTT; Woodway Loco-system) which allows a portion of an individual's body-weight
      to be counterbalanced by an overhead pulley system. This system allows patients with limited
      mobility to walk upright on the treadmill with therapist assistance. Therapists trained in
      using the BWSTT system will guide the patients' legs through a proper gait motion and assist
      with lower limb control. Participants will complete 72 training sessions (30min/session,
      3x/week) over the course of 24 weeks. Participants will be evaluated at baseline, 12 weeks
      (half-way through the training program) and 24 weeks (end of intervention). A follow-up
      assessment will also be performed 12 after participants have completed the training program
      (36 weeks). Outcome measures are described below.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2008</start_date>
  <completion_date type="Actual">June 2009</completion_date>
  <primary_completion_date type="Actual">June 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change from baseline in Multiple Sclerosis Functional Composite (MSFC) at 12, 24 and 36 weeks</measure>
    <time_frame>Repeat assessments: baseline, 12 weeks, 24 weeks and 36 weeks (12 weeks post-exercise follow-up)</time_frame>
    <description>The MSFC assesses functional ability with three scales: the 25ft walk (leg strength and ambulation), the 9-hole peg test (arm strength and coordination) and the Paced Auditory Serial Addition Test (PASAT; cognition). Scores on all three measures are combined to produce a composite Z-score.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in Expanded Disability Status Scale (EDSS) at 12, 24 and 36 weeks</measure>
    <time_frame>Repeat assessments: baseline, 12 weeks, 24 weeks and 36 weeks (12 weeks post-exercise follow-up)</time_frame>
    <description>The EDSS provides a measure of physical and neurological function specifically in MS patients and is scored from 0-10. This will be assessed by a train neurologist.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in Modified Fatigue Impact Scale (MFIS) at 12, 24 and 36 weeks</measure>
    <time_frame>Repeat assessments: baseline, 12 weeks, 24 weeks and 36 weeks (12 weeks post-exercise follow-up)</time_frame>
    <description>The MFIS is a 21-item self-report questionnaire that evaluates fatigue overall fatigue, as well as within three categories: physical (pMFIS); cognitive (cMFIS); and psychosocial (psMFIS), over the previous 4 weeks. Scores range from 0-4 on each item with a maximum total score of 84, where higher scores indicate greater fatigue levels.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in Multiple Sclerosis Quality of Life-54 questionnaire at 12, 24 and 36 weeks</measure>
    <time_frame>Repeat assessments: baseline, 12 weeks, 24 weeks and 36 weeks (12 weeks post-exercise follow-up)</time_frame>
    <description>The MSQOL-54 is an MS-specific measure of quality of life that consists of 54 items divided into 12 multi-item scales, 2 single-item scales, and 2 composite scores (physical and mental health).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in brain-derived neurotrophic factor (BDNF) at 12, 24 and 36 weeks</measure>
    <time_frame>Repeat assessments: baseline, 12 weeks, 24 weeks and 36 weeks (12 weeks post-exercise follow-up)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in magnetic resonance imaging (MRI) outcomes at 24 weeks</measure>
    <time_frame>Repeat assessments: baseline and 24 weeks</time_frame>
    <description>Both standard and unconventional MRI techniques will be used to evaluate the effects of exercise on brain health.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">6</enrollment>
  <condition>Multiple Sclerosis</condition>
  <arm_group>
    <arm_group_label>Body-weight supported treadmill training</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Body-weight supported treadmill training</intervention_name>
    <description>Patients will undergo training using the Woodway Loco-system which consists of a treadmill with an overhead pulley system connected to a support harness. BWSTT allows patients with limited mobility to safely walk upright on a treadmill with a portion of their body weight counter balanced. Three trainers will be required to assist with the BWSTT program. Two trainers will be positioned at the lower limbs to manually guide the participant through a proper gait motion and provided lower limb control. A third trainer will stand behind the participant to provide trunk support and assist with weight shifting.</description>
    <arm_group_label>Body-weight supported treadmill training</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Signed, written informed consent

          -  Males or non-pregnant females, 18-60 years of age (inclusive)

          -  Clinically definite PPMS as per the diagnostic criteria of Thompson et al (2000)

          -  Expanded disability status score 5.0-8.0 (constant assistance required)

          -  Body weight &lt;90kg (due to support limitations of treadmill)

          -  Approval from physician to participate in the exercise program

          -  Ability to tolerate upright locomotion of the body weight supported treadmill

          -  Ability to visit the different sites required for the study

          -  Ability to commit to 3 weekly training sessions for the duration of 24 weeks

        Exclusion Criteria:

          -  Any disability acquired from trauma or another illness that could interfere with
             evaluation of disability due to MS

          -  Any other serious medical condition that might impair the subject's ability to walk on
             a treadmill and/or participate in aerobic exercise (including but not limited to:
             documented heart disease or unstable angina, uncontrolled cardiac dysrhythmia, chronic
             obstructive lung disease, recent non-traumatic fracture, osteoporosis and severe skin
             ulcerations)

          -  Female patients who do not agree to use effective contraceptive method(s) during the
             study

          -  Current use or use within the last 2 months of any on- or off-label disease-modifying
             therapy including IFN-Î², glatiramer acetate, IV steroids, mitoxantrone, azathioprine,
             and cyclophosphamide

          -  Previous experience with supported treadmill training

          -  Kidney disease, peripheral vascular disease or poor circulation

          -  Inability to undergo MRI or MRI with gadolinium administration
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michel Rathbone, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>McMaster University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Audrey Hicks, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>McMaster University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>McMaster University (Centre for Health Promotion and Rehabilitation)/Hamilton Health Sciences</name>
      <address>
        <city>Hamilton</city>
        <state>Ontario</state>
        <zip>L8S 4K1</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <results_reference>
    <citation>Pilutti LA, Lelli DA, Paulseth JE, Crome M, Jiang S, Rathbone MP, Hicks AL. Effects of 12 weeks of supported treadmill training on functional ability and quality of life in progressive multiple sclerosis: a pilot study. Arch Phys Med Rehabil. 2011 Jan;92(1):31-6. doi: 10.1016/j.apmr.2010.08.027.</citation>
    <PMID>21187202</PMID>
  </results_reference>
  <verification_date>April 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 18, 2011</study_first_submitted>
  <study_first_submitted_qc>April 19, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 20, 2011</study_first_posted>
  <last_update_submitted>April 19, 2011</last_update_submitted>
  <last_update_submitted_qc>April 19, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 20, 2011</last_update_posted>
  <responsible_party>
    <name_title>Audrey Hicks</name_title>
    <organization>McMaster University</organization>
  </responsible_party>
  <keyword>treadmill exercise</keyword>
  <keyword>rehabilitation</keyword>
  <keyword>progressive multiple sclerosis</keyword>
  <keyword>functional ability</keyword>
  <keyword>quality of life</keyword>
  <keyword>fatigue</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sclerosis</mesh_term>
    <mesh_term>Multiple Sclerosis</mesh_term>
    <mesh_term>Multiple Sclerosis, Chronic Progressive</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

